ALPS Advisors’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $925K | Buy |
+53,000
| New | +$925K | 0.01% | 516 |
|
|
2024
Q4 | – | Sell |
-70,578
| Closed | -$1.02M | – | 1038 |
|
|
2024
Q3 | $1.02M | Sell |
70,578
-5,026
| -7% | -$72.9K | 0.01% | 484 |
|
|
2024
Q2 | $643K | Buy |
75,604
+7,896
| +12% | +$67.2K | ﹤0.01% | 544 |
|
|
2024
Q1 | $692K | Buy |
67,708
+1,312
| +2% | +$13.4K | ﹤0.01% | 554 |
|
|
2023
Q4 | $364K | Sell |
66,396
-4,104
| -6% | -$22.5K | ﹤0.01% | 733 |
|
|
2023
Q3 | $266K | Buy |
70,500
+838
| +1% | +$3.17K | ﹤0.01% | 906 |
|
|
2023
Q2 | $467K | Buy |
+69,662
| New | +$467K | ﹤0.01% | 625 |
|